Evotec SE (EVO) Earnings Date & Reports

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

EVO is expected to report earnings to rise 42.84% to -21 cents per share on November 05

Q3'26

Est.

$-0.21

Q2'26

Missed

by $0.13

Q1'26

Missed

by $0.23

Q4'25

Beat

by $0.02

Q3'25

Beat

by $0.03

The last earnings report on August 13 showed earnings per share of -15 cents, missing the estimate of -1 cents. With 29.76K shares outstanding, the current market capitalization sits at 696.97M.

View a ticker or compare two or three

EVO

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days